Literature DB >> 15942194

Hyaluronan: a critical component of epithelial-mesenchymal and epithelial-carcinoma transitions.

Bryan P Toole1, Alexandra Zoltan-Jones, Suniti Misra, Shibnath Ghatak.   

Abstract

Hyaluronan plays a central role in the transition of epithelia to mesenchyme in the embryo and in the acquisition of transformed properties in carcinoma cells. In some cases, hyaluronan is both essential and sufficient for induction of epithelial-mesenchymal transitions (EMTs). Underlying its role are the effects of hyaluronan on receptor kinase activities, cell survival pathways, and multidrug transporters. A more complete understanding of the mechanisms whereby hyaluronan exerts its influences on cell behavior will enhance our understanding of normal and pathological EMTs and may lead to improved therapies for cancer patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15942194     DOI: 10.1159/000084510

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.481


  35 in total

Review 1.  Aspects of the biology of hyaluronan, a largely neglected but extremely versatile molecule.

Authors:  Karl M Stuhlmeier
Journal:  Wien Med Wochenschr       Date:  2006-11

2.  Binding of trastuzumab to ErbB2 is inhibited by a high pericellular density of hyaluronan.

Authors:  Tímea Váradi; Tamás Mersich; Päivi Auvinen; Raija Tammi; Markku Tammi; Ferenc Salamon; István Besznyák; Ferenc Jakab; Zsolt Baranyai; János Szöllősi; Peter Nagy
Journal:  J Histochem Cytochem       Date:  2012-05-04       Impact factor: 2.479

3.  Hyaluronan synthase 2 overexpression is correlated with the tumorigenesis and metastasis of human breast cancer.

Authors:  Peng Li; Tingxiu Xiang; Hongzhong Li; Qianqian Li; Bing Yang; Jing Huang; Xiang Zhang; Yuan Shi; Jinxiang Tan; Guosheng Ren
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

4.  Synthesis and organization of hyaluronan and versican by embryonic stem cells undergoing embryoid body differentiation.

Authors:  Shreya Shukla; Rekha Nair; Marsha W Rolle; Kathleen R Braun; Christina K Chan; Pamela Y Johnson; Thomas N Wight; Todd C McDevitt
Journal:  J Histochem Cytochem       Date:  2009-12-21       Impact factor: 2.479

5.  Prostate cancer increases hyaluronan in surrounding nonmalignant stroma, and this response is associated with tumor growth and an unfavorable outcome.

Authors:  Andreas Josefsson; Hani Adamo; Peter Hammarsten; Torvald Granfors; Pär Stattin; Lars Egevad; Anna Engström Laurent; Pernilla Wikström; Anders Bergh
Journal:  Am J Pathol       Date:  2011-08-18       Impact factor: 4.307

6.  Hyaluronan synthesis and myogenesis: a requirement for hyaluronan synthesis during myogenic differentiation independent of pericellular matrix formation.

Authors:  Liam C Hunt; Chris Gorman; Christopher Kintakas; Daniel R McCulloch; Eleanor J Mackie; Jason D White
Journal:  J Biol Chem       Date:  2013-03-14       Impact factor: 5.157

7.  Tumor necrosis factor-alpha regulates transforming growth factor-beta-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-moesin interaction.

Authors:  Eri Takahashi; Osamu Nagano; Takatsugu Ishimoto; Toshifumi Yae; Yoshimi Suzuki; Takeshi Shinoda; Satoshi Nakamura; Shinichiro Niwa; Shun Ikeda; Hisashi Koga; Hidenobu Tanihara; Hideyuki Saya
Journal:  J Biol Chem       Date:  2009-12-04       Impact factor: 5.157

8.  Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing.

Authors:  Alamelu G Bharadwaj; Joy L Kovar; Eileen Loughman; Christian Elowsky; Gregory G Oakley; Melanie A Simpson
Journal:  Am J Pathol       Date:  2009-02-13       Impact factor: 4.307

Review 9.  Engineering three-dimensional stem cell morphogenesis for the development of tissue models and scalable regenerative therapeutics.

Authors:  Melissa A Kinney; Tracy A Hookway; Yun Wang; Todd C McDevitt
Journal:  Ann Biomed Eng       Date:  2013-12-03       Impact factor: 3.934

Review 10.  Glycosylation in bladder cancer.

Authors:  Chikara Ohyama
Journal:  Int J Clin Oncol       Date:  2008-08-15       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.